AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

List of Komodo Healthcare Map Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Alnylam Pharmaceuticals, Inc. Life Sciences 2002 $1.0B United States Komodo Health Komodo Healthcare Map Analytics and BI 2019 n/a
In 2019, Alnylam Pharmaceuticals, Inc. implemented Komodo Healthcare Map to support commercial analytics and go to market prioritization. The deployment targeted the Global Commercial Excellence organization and adjacent commercial functions, aligning the Komodo Healthcare Map with account prioritization and field targeting workflows for sales and commercial operations. Komodo Healthcare Map was configured to deliver population level and patient level analytics, cohort identification, geospatial mapping, provider and specialty segmentation, and executive dashboards. The implementation emphasized interactive visualization and cohort discovery capabilities to support account-level engagement planning and commercial segmentation, with role specific dashboards provisioned for commercial leadership and field teams. Operational coverage focused on commercial excellence and GTM planning rather than clinical R&D workflows, with the Komodo Healthcare Map used to inform territory focus, target selection, and campaign prioritization. Implementation narrative centers on analytics-driven decision support, demand shaping, and evidence based targeting for sales and market access stakeholders. Governance changes included centralized access to Komodo Healthcare Map outputs and process adjustments for how targets are nominated and prioritized by the Global Commercial Excellence team. According to John Garcia, Global Commercial Excellence Lead, Komodo Health has really helped to focus people in the right area, and that’s been a huge boost for our organization, an explicit outcome cited by the customer.
Karyopharm Therapeutics Life Sciences 385 $157M United States Komodo Health Komodo Healthcare Map Analytics and BI 2019 n/a
In 2019 Karyopharm Therapeutics implemented Komodo Healthcare Map as an Analytics and BI capability to accelerate clinical trial targeting for COVID-19 related work. Komodo Healthcare Map was deployed rapidly to provide a ground-up, real-time view that threads clinical sites, physician engagement, and patient cohorts for trial planning and outreach. The implementation used Komodo’s real-time data to support cohort identification, provider targeting, site selection, and validation workflows, leveraging Analytics and BI functionality such as interactive visualization and rapid cohort generation. Functional emphasis was on patient-level and provider-level analytics to reach infectious disease physicians and validate targeting hypotheses, consistent with category-aligned reporting, segmentation, and operational dashboards. Operational scope centered on Global Medical and Scientific Affairs and clinical operations, with the platform used to accelerate targeting and validation for an upcoming global clinical trial. Karyopharm reported that Komodo’s technology and rapid deployment timeline enabled faster targeting of the right physicians, and that the vendor’s support would be critical to maximize the speed and efficiency of the trial.
Omeros Corporation Life Sciences 213 $73M United States Komodo Health Komodo Healthcare Map Analytics and BI 2018 n/a
In 2018, Omeros Corporation implemented Komodo Healthcare Map. The Komodo Healthcare Map deployment addressed Analytics and BI needs to accelerate commercial launch readiness, explicitly supporting sales and commercial strategy functions during a product launch period. The implementation focused on core Analytics and BI capabilities common to real-world data platforms, including interactive cohort identification, patient-level longitudinal analytics, visualization and reporting workflows, and self-service query and analysis for commercial teams. Komodo Healthcare Map was configured to surface actionable patient and prescriber insights for go-to-market planning and sales targeting, with emphasis on speed and usability for non-technical users. Deployment was completed in a matter of weeks rather than months, enabling rapid operational use by sales, commercial strategy, and analytics teams preparing for launch. The engagement did not list external systems integrations in source notes, so the rollout emphasized direct platform adoption and internal workflow alignment within commercial operations. Bill Woodman, Vice President of Sales at Omeros Corporation, reported the implementation achieved in weeks what would have taken months with consultants, described the software as fast and user-friendly, and stated Komodo Healthcare Map continues to be a key part of Omeros Corporation's strategy.
PSC Partners Seeking a Cure Life Sciences 15 $1M United States Komodo Health Komodo Healthcare Map Analytics and BI 2019 n/a
In 2019 PSC Partners Seeking a Cure implemented Komodo Healthcare Map through a partnership with Komodo Health to support research and improve health outcomes for Primary Sclerosing Cholangitis patients. Komodo Healthcare Map was provisioned as an Analytics and BI platform to provide patient level and population level real world evidence analytics, cohort identification, and longitudinal patient journey visualization tailored to the needs of a small, US based life sciences non profit focused on a rare disease. Deployment centered on a cloud hosted instance of Komodo Healthcare Map configured for registry augmentation, targeted cohort discovery, and outcomes querying, with role based access controls and analytic workspaces aligned to research and clinical outreach workflows. Governance emphasized data stewardship and workflow coordination between the advocacy organization and clinical research functions, enabling PSC Partners Seeking a Cure to operationalize patient identification and evidence generation to support efforts to improve patient outcomes for PSC patients.
Veradigm (formerly Allscripts) Professional Services 2450 $589M United States Komodo Health Komodo Healthcare Map Analytics and BI 2019 n/a
In 2019, Veradigm implemented Komodo Healthcare Map as an Analytics and BI deployment through a long-term strategic partnership with Komodo Health. Veradigm, an Allscripts business unit, linked its ambulatory EHR data into Komodo Healthcare Map to produce a consolidated, longitudinal research dataset containing nearly 50 million deidentified patients. The implementation centralized encounter-level claims aggregation and patient-level longitudinal record linkage within Komodo Healthcare Map, aligning ambulatory EHR records with encounter data from more than 150 private and public payers. The work included curated deidentification and dataset curation workflows to generate research-ready cohorts and enable observational study design and evidence generation consistent with Analytics and BI capabilities. Technically the project ingested Veradigm ambulatory EHR feeds and mapped EHR identifiers to Komodo Healthcare Map encounter streams using record linkage and mapping processes. Operational coverage focused on life sciences research use cases, with the linked dataset provisioned to support life sciences companies investigating clinical outcomes and disease burden reduction. The engagement formalized a long-term strategic data governance arrangement between Veradigm and Komodo Health, emphasizing deidentification controls, data stewardship, and controlled research access. The Komodo Healthcare Map linked dataset is positioned to enable life sciences research by combining Allscripts ambulatory EHR content with payer encounter data to support cohort discovery and longitudinal analyses.
Showing 1 to 5 of 5 entries

Buyer Intent: Companies Evaluating Komodo Healthcare Map

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Komodo Healthcare Map. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Komodo Healthcare Map for Analytics and BI include:

  1. Healthverity, a United States based Professional Services organization with 25 Employees
  2. Teach Me GIS, a United States based Education company with 20 Employees
  3. Hyosung Corporation, a South Korea based Manufacturing organization with 25000 Employees

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
Healthverity Professional Services 25 $3M United States 2025-09-12
Teach Me GIS Education 20 $2M United States 2025-02-26
Hyosung Corporation Manufacturing 25000 $3.2B South Korea 2025-02-19
Life Sciences 1500 $200M United States 2025-02-11
Professional Services 64505 $1.3B India 2024-12-23
FAQ - APPS RUN THE WORLD Komodo Healthcare Map Coverage

Komodo Healthcare Map is a Analytics and BI solution from Komodo Health.

Companies worldwide use Komodo Healthcare Map, from small firms to large enterprises across 21+ industries.

Organizations such as Alnylam Pharmaceuticals, Inc., Veradigm (formerly Allscripts), Karyopharm Therapeutics, Omeros Corporation and PSC Partners Seeking a Cure are recorded users of Komodo Healthcare Map for Analytics and BI.

Companies using Komodo Healthcare Map are most concentrated in Life Sciences and Professional Services, with adoption spanning over 21 industries.

Companies using Komodo Healthcare Map are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Komodo Healthcare Map across Americas, EMEA, and APAC.

Companies using Komodo Healthcare Map range from small businesses with 0-100 employees - 20%, to mid-sized firms with 101-1,000 employees - 40%, large organizations with 1,001-10,000 employees - 40%, and global enterprises with 10,000+ employees - 0%.

Customers of Komodo Healthcare Map include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Komodo Healthcare Map customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Analytics and BI.